DISIT BIOTECH
Pioneering drug research to transform radiation-related damage into new therapeutic opportunities — improving cancer patients' life quality and expectancy.
Our Science
How are we leveraging the power of peptide-based therapies to pioneer new solutions? Discover how these therapies are driving groundbreaking treatments.
Disit Team
Meet the passionate team at DISIT Biotech, dedicated to driving innovation in biotechnology and transforming ideas into breakthroughs.
Rafael González
Chief Executive Officer & Founder
Know More
Entrepreneur with a solid academic background. Founder partner and board member of Galistair a commercial airline, leading financial and strategy divisions. Large experience in international senior management positions. R&D experience in hi-tech products. Expertise in business strategy, negotiation, market intelligence, business expansion and strategic marketing in over 40 countries of technological solutions with high added value.
Javier Dotor, PhD
Chief Scientific Officer & Founder
Know More
Over 25 year of experience in the biotechnology sector and pharmaceutical products development industry. Highest cumulative expertise in the active compound (Disitertide) and its molecular target (TGF-β). Author in more than 35 research papers of Disitertide efficacy proofs of concept. Author in 6 patent families enclosing Disitertide clinical applications. Transversal knowledge and approach to drug development pathway, from early research to advance clinical development.
Gabriel Gallo Oller, PhD
Senior investigator
Know More
Dynamic researcher with over 15 years of experience in impactful studies on therapeutic molecular pathways in cancer. Recognized for evaluating inhibitors and conducting preclinical evaluations in academia and in collaboration with the industry. Extensive expertise in Disitertide, TGF-β, in vitro and in vivo models fine-tuning for preclinical cancer research and dedicated to translating research into clinical applications.
María Isabel Guillén Antonini, MSc
Senior Technician
Know More
Extensive experience in analysis and quality control, supported by a 10-year career. Qualified and experienced in a wide range of chemical and biomedical laboratory procedures in the research sector. Highly resourceful and versatile profile in cell culture, biochemical, and pre-formulation procedures, as well as in handling complex equipment.
Alma Chiesa Pérez
Technician
Know More
Expertise in pharmaceutical formulation and physico-chemical characterization. Skilled in optimizing laboratory techniques with a strong learning capacity. Brings organizational and collaboration skills to ensure project completion and effective communication within the R&D team, driving innovation and efficiency in developing high-quality solutions
Pipeline
DISIT's pipelines drive innovation in biotechnology, encompassing groundbreaking research, preclinical studies, and clinical development. Focused on precision and quality, we deliver cutting-edge solutions to advance science and improve lives, ensuring progress through every stage of discovery and development.
DISIT Biotech focused on generating clinical solutions based on TGF-β inhibition for unmeet oncological complications with a pharmaceutical ingredient with potential for multiple therapies.
Committed to innovation and excellence, on the path of developing clinical solutions that impact globally on the quality and life expectancy of oncology patients.
News and Articles
We stay proactive and think big. Stay informed about our latest research news.
Awards & Grants
Award Innovative Project 2022 at Innova Health Congress
Torres Quevedo Program for the Recruitment of PhD Researchers
SiloAceleraBio Acceleration Program for Startups and Innovative Projects in Life Sciences
Innovative Pyme Award - Valid until 2028
References
